Patents by Inventor Matthew Iyer

Matthew Iyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NcRNA and uses thereof
    Patent number: 12270080
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: April 8, 2025
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer
  • ncRNA AND USES THEREOF
    Publication number: 20230016456
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Application
    Filed: July 18, 2022
    Publication date: January 19, 2023
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer
  • ncRNA and uses thereof
    Patent number: 11390923
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: July 19, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer
  • Non-coding RNAS and uses thereof
    Patent number: 10889864
    Abstract: Provided herein are compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, provided herein are non-coding RNAs as diagnostic markers and clinical targets for cancer.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: January 12, 2021
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul Chinnaiyan, Felix Y. Feng, John Prensner, Matthew Iyer, Yashar Niknafs
  • ncRNA AND USES THEREOF
    Publication number: 20200224276
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Application
    Filed: July 26, 2019
    Publication date: July 16, 2020
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer
  • ncRNA AND USES THEREOF
    Publication number: 20200165682
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Application
    Filed: June 26, 2019
    Publication date: May 28, 2020
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer
  • Schlap-1 ncRNA and uses thereof
    Patent number: 10407735
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: September 10, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer
  • ncRNA AND USES THEREOF
    Publication number: 20160348184
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Application
    Filed: May 17, 2016
    Publication date: December 1, 2016
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer
  • ncRNA AND USES THEREOF
    Publication number: 20160251729
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Application
    Filed: March 8, 2016
    Publication date: September 1, 2016
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer
  • NON-CODING RNAS AND USES THEREOF
    Publication number: 20160160295
    Abstract: Provided herein are compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, provided herein are non-coding RNAs as diagnostic markers and clinical targets for cancer.
    Type: Application
    Filed: December 8, 2015
    Publication date: June 9, 2016
    Inventors: ARUL CHINNAIYAN, FELIX Y. FENG, JOHN PRENSNER, MATTHEW IYER, YASHAR NIKNAFS
  • ncRNA AND USES THEREOF
    Publication number: 20150284802
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Application
    Filed: November 17, 2011
    Publication date: October 8, 2015
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer
  • ncRNA AND USES THEREOF
    Publication number: 20130267443
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast and pancreatic cancer.
    Type: Application
    Filed: March 12, 2013
    Publication date: October 10, 2013
    Applicant: The Regents of the University of Michigan
    Inventors: Arul Chinnaiyan, John Prensner, Matthew Iyer